title: [A case of type 4 gastric cancer with positive peritoneal lavage cytology, which relapsed at the peritoneum at the time of seven years and eight months after resection].
abstract: A 55-year-old woman was admitted to our hospital with a complaint of appetite loss and body weight loss. Upper digestive endoscopy showed a giant fold at the greater curvature stomach and diffused edematous gastric mucosa. Abdominal contrast CT demonstrated a significant thickening of the gastric wall and a large number of lymph node swelling. A clinical finding was Stage IIIB (T3N2M0) Type 4 gastric cancer of poorly differentiated adenocarcinoma. Total gastrectomy, splenectomy and D2 lymph node dissection were performed. Although there was no peritoneal dissemination, peritoneal lavage cytology was positive. After the operation, S-1 alone chemotherapy was administered for four years. No recurrence had occurred for about seven years and eight months after resection. However, the patient was pointed out the signs of recurrence (ascites and induration) by CT. Now, S-1 alone chemotherapy was performed again, and the patient has been in good health.
authors.affiliation: Dept. of Surgical Oncology, Osaka City University Graduate School of Medicine.
authors.forename: Masanori
authors.initials: M
authors.lastname: Nakamura
authors.forename: Naoshi
authors.initials: N
authors.lastname: Kubo
authors.forename: Junya
authors.initials: J
authors.lastname: Morimoto
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Tanaka
authors.forename: Kazuya
authors.initials: K
authors.lastname: Muguruma
authors.forename: Ryosuke
authors.initials: R
authors.lastname: Amano
authors.forename: Eiji
authors.initials: E
authors.lastname: Noda
authors.forename: Toru
authors.initials: T
authors.lastname: Inoue
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Takashima
authors.forename: Nobuya
authors.initials: N
authors.lastname: Yamada
authors.forename: Masakazu
authors.initials: M
authors.lastname: Yashiro
authors.forename: Yoshito
authors.initials: Y
authors.lastname: Yamashita
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Maeda
authors.forename: Naoyoshi
authors.initials: N
authors.lastname: Onoda
authors.forename: Tetsuji
authors.initials: T
authors.lastname: Sawada
authors.forename: Bunzo
authors.initials: B
authors.lastname: Nakata
authors.forename: Masaichi
authors.initials: M
authors.lastname: Ohira
authors.forename: Tetsurou
authors.initials: T
authors.lastname: Ishikawa
authors.forename: Kosei
authors.initials: K
authors.lastname: Hirakawa
mesh_terms: D002293:Adenocarcinoma, Scirrhous / Q000473:pathology* / Q000628:therapy; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005743:Gastrectomy; D006801:Humans; D008197:Lymph Node Excision; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010094:Oxonic Acid / Q000627:therapeutic use; D010533:Peritoneal Lavage; D013156:Splenectomy; D013274:Stomach Neoplasms / Q000473:pathology* / Q000628:therapy; D005641:Tegafur / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; C079198:S 1 (combination); D005641:Tegafur; D010094:Oxonic Acid